Created in September 2009 by Institut Mérieux, Mérieux Développement is part of its global innovation strategy.

   ZOOM >>>

Institut Mérieux is committing its experience in industrial biology to serve medicine and public health across the globe.

To fight against infectious diseases and cancers, it imagines and develops new approaches in the fields of diagnostics, immunotherapy, food safety and nutrition.

Since its creation, Institut Mérieux has always placed science and research at the core of its activities.

Its three companies - bioMérieux, Transgene, Silliker - have made major advances in the fight against  diseases and in the field of prevention.

Chaired by Alain Mérieux, Institut Mérieux employs close to 10,000 people committed to global public health.
It is present in over 40 countries, and generates sales of over €1.3 billion.